Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer.

Eleni Andreopoulou; D. Andreopoulos; Konstantinos Adamidis; A Fountzila-Kalogera; George Fountzilas; Meletios A Dimopoulos; Gerasimos Aravantinos; Nikolaos Zamboglou; Dimos Baltas; N. Pavlidis

Abstract

1 min read

Tumor volumetry in advanced ovarian cancer was found to have predictive value for response to platinum-based chemotherapy. Initial tumor volume has prognostic significance only for the time to progression, whereas residual tumor volume has for both time to progression and survival.

Related publications

Article2007

Evaluation of the prognostic significance of human kallikrein 8 protein expression levels in advanced ovarian cancer by using automated quantitative protein analysis

P. Kountourakis, Amanda Psyrri, Andreas Scorilas, S. Markakis, Diane Kowalski, R. L. Camp, Eleftherios P. Diamandis, Meletios A Dimopoulos

Article2009

Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis

Andreas Scorilas, Sonia Markakis, Diane Kowalski, Robert L. Camp, Eleftherios P. Diamandis, Meletios A Dimopoulos, Panteleimon Kountourakis, Amanda Psyrri

Article2008

Prognostic value of kallikrein‐related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA)

Panteleimon Kountourakis, Amanda Psyrri, Andreas Scorilas, Robert L. Camp, Sonia Markakis, Diane Kowalski, Eleftherios P. Diamandis, Meletios A Dimopoulos

Preprint2021

Neutrophil-to-Lymphocyte Ratio and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant Chemotherapy

Michalis Liontos, Angeliki Andrikopoulou, Konstantinos Koutsoukos, Christos Markellos, Efthymia Skafida, Oraianthi Fiste, Maria Kaparelou, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Meletios A Dimopoulos, Flora Zagouri

Article2021

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting

Michalis Liontos, Alkistis Papatheodoridi, Αngeliki Andrikopoulou, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Flora Zagouri, Aristotelis Bamias, Meletios A Dimopoulos